iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Sees Significant Drop in Short Interest

iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) was the recipient of a large decline in short interest in December. As of December 31st, there was short interest totaling 1,277 shares, a decline of 86.5% from the December 15th total of 9,491 shares. Approximately 0.0% of the company’s shares are short sold. Based on an average daily volume of 17,516 shares, the short-interest ratio is presently 0.1 days. Based on an average daily volume of 17,516 shares, the short-interest ratio is presently 0.1 days. Approximately 0.0% of the company’s shares are short sold.

Institutional Investors Weigh In On iShares Genomics Immunology and Healthcare ETF

Several hedge funds have recently made changes to their positions in IDNA. Triumph Capital Management bought a new position in iShares Genomics Immunology and Healthcare ETF in the third quarter worth $35,000. Ameriprise Financial Inc. boosted its stake in iShares Genomics Immunology and Healthcare ETF by 8.4% during the third quarter. Ameriprise Financial Inc. now owns 71,473 shares of the company’s stock worth $1,688,000 after acquiring an additional 5,540 shares in the last quarter. Portland Global Advisors LLC grew its holdings in iShares Genomics Immunology and Healthcare ETF by 0.7% in the third quarter. Portland Global Advisors LLC now owns 103,007 shares of the company’s stock worth $2,432,000 after purchasing an additional 684 shares during the period. Finally, Flow Traders U.S. LLC purchased a new stake in iShares Genomics Immunology and Healthcare ETF in the second quarter worth about $931,000.

iShares Genomics Immunology and Healthcare ETF Price Performance

IDNA stock traded up $0.23 during trading on Tuesday, reaching $27.87. The company had a trading volume of 20,724 shares, compared to its average volume of 45,753. iShares Genomics Immunology and Healthcare ETF has a 52 week low of $17.26 and a 52 week high of $28.10. The business has a 50 day moving average of $26.45 and a 200 day moving average of $24.06. The company has a market cap of $139.35 million, a P/E ratio of 14.76 and a beta of 1.07.

iShares Genomics Immunology and Healthcare ETF Company Profile

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.